Skip to content
OpenCapital
Get started

AirSculpt Technologies, Inc. AIRS EPS (Basic)

EPS (Basic) at other companies

Eli Lilly logo
Eli LillyLLY
$8.27+169%
AbbVie logo
AbbVieABBV
$0.39-45.8%
Establishment Labs logo
Establishment LabsESTA
-$0.45+35.7%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$3.82-2,287%

Other financials

Income statement

See full
Revenue$39.4M0.0%
Gross profit$23.8M+1.6%
Operating income-$1.8M-13.4%
Net income-$2.4M+15.8%
EPS (diluted)-$0.03+40.0%

Balance sheet

See full
Cash & equivalents$16.7M+201%
Total debt$71.0M-27.1%
Total equity$100.3M+31.5%
Total assets$192.0M-5.5%

Cash flow

See full
Operating cash flow$5.3M+507%
CapEx$51.0K-97.3%
Free cash flow$5.2M+605%

Valuation

See full
Market cap$311.81M+4.7%
Enterprise value$366.14M-6.0%
P/S2.1×+0.3×

Profitability

See full
Gross margin59.6%-0.3pp
Operating margin-7.8%-0.4pp
Net margin-11.3%-25.1pp
FCF margin-0.1%—

Returns & leverage

See full
Return on equity-21.6%-78.3pp
Debt / equity0.7×-0.6×
Current ratio0.7×+0.2×

Where this comes from

Reported directly by AirSculpt Technologies, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EarningsPerShareBasic.

The official record: AirSculpt Technologies, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AirSculpt Technologies, Inc.'s eps (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AirSculpt Technologies, Inc.'s EPS (basic)?
AirSculpt Technologies, Inc. (AIRS) reported EPS (basic) of -$0.03 in Q1 2026.
How has AirSculpt Technologies, Inc.'s EPS (basic) changed year-over-year?
AirSculpt Technologies, Inc.'s EPS (basic) increased by 40.0% year-over-year, from -$0.05 to -$0.03.
What is the long-term trend for AirSculpt Technologies, Inc.'s EPS (basic)?
Over 3 years (2021 to 2024), AirSculpt Technologies, Inc.'s EPS (basic) has grown at a 141.0% compound annual growth rate (CAGR), from -$0.01 to -$0.14.
What does EPS (basic) mean?
Net income available to common shareholders divided by the weighted-average number of common shares outstanding during the period. Does not account for dilutive securities.